E-Z-EM to Strengthen Bracco’s Diagnostic Imaging Business; Merger to Close in April

E-Z-EM, a diversified provider of contrast agents for gastrointestinal radiology, will be acquired by Bracco Diagnostics, the U.S.-based subsidiary of Bracco Imaging S.p.A., for $241 million in cash. The merger is expected to close sometime in early April.

Under the terms of the agreement, EZ stockholders will receive $21 per share in cash. In October, when the merger was announced, EZ had been trading in the $16 range.

E-Z-EM markets approximately 30 fluoroscopy formulations, 11 varieties of CT contrast media, and radiological medical devices, such as entry biopsy needles and trays and mammography wipes.

source: OneMedPlace